I think it could. It depends what responsibilities of mwip 800c is assuming. I think it may short term from the sheer fact that part of mwip's pps is based off future patient registration. Mwip loses that potential revenue even though it is the parent company of 800c. However they still have the revenue from chillo and cswiss which are already generating profit for mwip. We can speculate as much as we want but it all comes down to market reception of the spinoff.